Company · CIK 0001022899 · SIC 2834 — Pharmaceutical Preparations · OTC
Protagenic Therapeutics, Inc.\new · PTIX
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 21, 2026 PForm 4 → | Aug 24, 1:20 pm EDT | Garo H ArmenEXEC. CHAIR & PRINCIPAL OFF, Director | 20,000 | $0.65 | $13,000 | 73,533 | +37.4% | |
| Aug 20, 2026 PForm 4 → | Aug 20, 8:20 pm EDT | Garo H ArmenEXEC. CHAIR & PRINCIPAL OFF, Director | 16,634 | $0.5898 | $9,811 | 53,533 | +45.1% | |
| Aug 19, 2026 PForm 4 → | Aug 20, 9:23 am EDT | Garo H ArmenEXEC. CHAIR & PRINCIPAL OFF, Director | 2,700 | $0.35 | $945 | 36,899 | +7.89% | |
| Aug 11, 2026 PForm 4 → | Aug 12, 6:51 pm EDT | Garo H ArmenEXEC. CHAIR & PRINCIPAL OFF, Director | 2,220 | $0.32 | $710 | 34,199 | +6.94% | |
| Aug 6, 2026 PForm 4 → | Aug 10, 10:17 am EDT | Garo H ArmenEXEC. CHAIR & PRINCIPAL OFF, Director | 685 | $0.22 | $151 | 31,979 | +2.19% | |
| Aug 5, 2026 PForm 4 → | Aug 6, 8:29 pm EDT | Garo H ArmenEXEC. CHAIR & PRINCIPAL OFF, Director | 5,000 | $0.2588 | $1,294 | 31,294 | +19.0% | |
| Jul 30, 2026 PForm 4 → | Aug 3, 5:29 pm EDT | Garo H ArmenEXEC. CHAIR & PRINCIPAL OFF., Director | 26,291 | $0.1828 | $4,806 | 26,291 | — | |
| Aug 8, 2016 AForm 4 → | Aug 10, 7:49 pm EDT | Khalil BarrageDirector | 150,000 | $1.25 | $187,500 | 245,000 | — | plan? |
| Jun 17, 2016 PForm 4 → | Aug 18, 4:35 pm EDT | Garo H ArmenSee Remarks, Director, 10% Owner | 60,211 | $1.25 | $75,264 | 4,299,379 | +1.42% | plan? late |
| Jun 17, 2016 AForm 4 → | Jun 22, 9:31 am EDT | Gregory EkizianDirector | 45,000 | $1.25 | $56,250 | 645,000 | — | plan? late |
| Jun 17, 2016 AForm 4 → | Jun 21, 9:56 pm EDT | Alexander K. ArrowChief Financial Officer | 140,000 | $1.25 | $175,000 | 358,260 | — | plan? |
| Jun 17, 2016 AForm 4 → | Jun 21, 9:55 pm EDT | Garo H ArmenSee Remarks, Director, 10% Owner | 500,000 | $1.25 | $625,000 | 4,239,168 | — | plan? |
| Jun 17, 2016 AForm 4 → | Jun 21, 9:53 pm EDT | Joshua SilvermanDirector | 45,000 | $1.25 | $56,250 | 45,000 | — | plan? |
| Jun 17, 2016 AForm 4 → | Jun 21, 9:47 pm EDT | Khalil BarrageDirector | 45,000 | $1.25 | $56,250 | 245,000 | — | plan? |
| Jun 17, 2016 AForm 4 → | Jun 21, 9:45 pm EDT | Robert Benjamin SteinDirector | 40,000 | $1.25 | $50,000 | 240,000 | — | plan? |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 16, 2017 AForm 4 → | Oct 18, 5:34 pm EDT | Brian CorveseDirector | 95,000 | — | — | 95,000 | — | |
| Oct 16, 2017 AForm 4 → | Oct 18, 2:46 pm EDT | Alexander K. ArrowChief Financial Officer | 75,000 | — | — | 75,000 | — | |
| Oct 16, 2017 AForm 4 → | Oct 18, 2:42 pm EDT | Garo H ArmenExecutive Chairman, Director, 10% Owner | 250,000 | — | — | 250,000 | — | |
| Oct 16, 2017 AForm 4 → | Oct 18, 2:23 pm EDT | Robert Benjamin SteinDirector | 200,000 | — | — | 200,000 | — | |
| Oct 16, 2017 AForm 4 → | Oct 18, 2:18 pm EDT | Joshua SilvermanDirector | 45,000 | — | — | 45,000 | — | |
| Oct 16, 2017 AForm 4 → | Oct 18, 2:13 pm EDT | Khalil BarrageDirector | 45,000 | — | — | 45,000 | — | |
| Apr 15, 2016 PForm 4 → | May 10, 3:25 pm EDT | Alexander K. ArrowChief Financial Officer | 58,260 | $1.25 | $72,825 | 118,260 | — | late |